NEULAND LABORATORIES
Back to Balance Sheet
|
NEULAND LABORATORIES Last 5 Year Capital Work in Progress History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Capital Work in Progress | ₹45 Cr | ₹46 Cr | ₹41 Cr | ₹20 Cr | ₹17 Cr |
What is the latest Capital Work in Progress ratio of NEULAND LABORATORIES ?
Year | Capital Work in Progress |
---|---|
Mar2025 | ₹45 Cr |
Mar2024 | ₹46 Cr |
Mar2023 | ₹41 Cr |
Mar2022 | ₹20 Cr |
Mar2021 | ₹17 Cr |
How is Capital Work in Progress of NEULAND LABORATORIES Trending?
Years | Capital Work in Progress | % Change | |
---|---|---|---|
Mar2025 | ₹45 Cr | -2.92 | |
Mar2024 | ₹46 Cr | 13.13 | |
Mar2023 | ₹41 Cr | 98.30 | |
Mar2022 | ₹20 Cr | 18.59 | |
Mar2021 | ₹17 Cr | - |
Compare Capital Work in Progress of peers of NEULAND LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NEULAND LABORATORIES | ₹19,582.6 Cr | 25.1% | 10.7% | 55.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹414,533.0 Cr | 0.6% | -0.4% | 4.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹180,215.0 Cr | -2.2% | 1.7% | 47.3% | Stock Analytics | |
CIPLA | ₹120,428.0 Cr | -0.2% | -1.4% | -1.9% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹116,410.0 Cr | 2.5% | 4.8% | 12.2% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,253.0 Cr | -2.6% | -8.1% | -4.9% | Stock Analytics |
NEULAND LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NEULAND LABORATORIES | 25.1% |
10.7% |
55.3% |
SENSEX | -1.4% |
0.7% |
2.4% |
You may also like the below Video Courses